Document is current
Any future updates will be listed below
-
Authors
Okanishi, Tohru
Fujimori, Ikuo https://orcid.org/0000-0002-5521-831X
Yamada, Mariko
Tajima, Takumi
Wataya-Kaneda, Mari
Seyama, Kuniaki
Hatano, Takashi
-
Funding
Funding for this research was provided by:
Novartis Pharma K.K
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 12 November 2024
First Online: 1 December 2024
Declarations
:
: This research does not contain identifiable patient information and was exempted from medical research ethics review based on the decision of the Institutional Ethics Committee of Tottori University Hospital.
: Not applicable.
: TO reports consulting fees and lecture fees from Novartis. KS reports consulting fees from Nobelpharma and Grifols SA; honoraria from Novartis, OrphanPacific, Kyorin Pharmaceuticals, Boehringer Ingelheim, and Japan Blood Products Organization; and is a committee member of the Japan Society of Pneumothorax and Cystic Lung Diseases and the Japanese Society of Tuberous Sclerosis Complex. MWK reports consulting fees from Novartis, Sanofi, Sumitomo Pharma, and AstraZeneca; and honoraria from Novartis, Nobelpharma, and Maruho. MY is an employee of Novartis Pharma K.K. IF was an employee of Novartis Pharma K.K during the study. TT is an employee of JMDC. TH reports no conflict of interest.
